Skip to Content
MilliporeSigma
All Photos(1)

Key Documents

8.52048

Sigma-Aldrich

Fmoc-Abu-OH

Novabiochem®

Synonym(s):

Fmoc-Abu-OH, N-α-Fmoc-L-α-aminobutyric acid, Fmoc-2-aminobutanoic acid

Sign Into View Organizational & Contract Pricing


About This Item

Empirical Formula (Hill Notation):
C19H19NO4
CAS Number:
Molecular Weight:
325.36
MDL number:
UNSPSC Code:
12352209
NACRES:
NA.22

Pricing and availability is not currently available.

Quality Level

product line

Novabiochem®

assay

≥90.0% (acidimetric)
≥98% (TLC)
≥98.0% (HPLC)

form

powder

reaction suitability

reaction type: Fmoc solid-phase peptide synthesis

manufacturer/tradename

Novabiochem®

mp

161-163 °C

application(s)

peptide synthesis

functional group

Fmoc

storage temp.

2-30°C

Compare Similar Items

View Full Comparison

Show Differences

1 of 4

This Item
8.520438.520498.52074
form

powder

form

powder

form

powder

form

powder

assay

≥90.0% (acidimetric), ≥98.0% (HPLC), ≥98% (TLC)

assay

≥96.0% (HPLC), ≥96.0% (acidimetric), ≥98% (TLC)

assay

≥95.0% (acidimetric), ≥98% (TLC), ≥99.0% (HPLC)

assay

≥94.0% (acidimetric), ≥97.0% (HPLC), ≥98% (TLC), ≥98% (perchloric acid titration)

functional group

Fmoc

functional group

Fmoc

functional group

Fmoc

functional group

Boc, amine

product line

Novabiochem®

product line

Novabiochem®

product line

Novabiochem®

product line

Novabiochem®

storage temp.

2-30°C

storage temp.

2-30°C

storage temp.

2-30°C

storage temp.

2-30°C

Quality Level

200

Quality Level

200

Quality Level

200

Quality Level

200

General description

Standard building block for introduction of aminobutyric amino-acid residues by Fmoc SPPS

Associated Protocols and Technical Articles
Cleavage and Deprotection Protocols for Fmoc SPPS

Application

Fmoc-Abu-OH Novabiochem®. CAS 135112-27-5, molar mass 325.36 g/mol.

Linkage

Replaces: 04-12-1099

Analysis Note

Color (visual): white to slight yellow to beige
Appearance of substance (visual): powder
Identity (IR): passes test
Enantiomeric purity: ≥ 99.0 % (a/a)
Purity (TLC(011A)): ≥ 98 %
Purity (TLC(0811)): ≥ 98 %
Assay (HPLC, area%): ≥ 98.0 % (a/a)
Solubility (1 mmole in 2 ml DMF): clearly soluble
Assay (acidimetric): ≥ 90.0 %
Water (K. F.): ≤ 6.0 %

To see the solvent systems used for TLC of Novabiochem® products please click here.

Legal Information

Novabiochem is a registered trademark of Merck KGaA, Darmstadt, Germany

Storage Class

11 - Combustible Solids

wgk_germany

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable


  • Certificates of Analysis (COA)

    Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

    Already Own This Product?

    Find documentation for the products that you have recently purchased in the Document Library.

    Visit the Document Library

    Timothy J Lansing et al.
    Molecular cancer therapeutics, 6(2), 450-459 (2007-02-03)
    Polo-like kinase 1 (PLK1) plays key roles in the regulation of mitotic progression, including mitotic entry, spindle formation, chromosome segregation, and cytokinesis. PLK1 expression and activity are strongly linked to proliferating cells. Many studies have shown that PLK1 expression is
    Julio Vera et al.
    Cellular signalling, 27(5), 951-960 (2015-02-17)
    In the present report, the role of ATR-Chk1-Wee1 and ATM-Chk2-p53-p21 pathways in stress-induced cell cycle control is analysed in melanoma cells. Treatment of p53 wild-type melanoma cells with the genotoxic agent doxorubicin induces G2-M arrest, inhibitory phosphorylation of cell cycle
    T Ikezoe et al.
    Leukemia, 23(9), 1564-1576 (2009-05-08)
    Polo-like kinase1 (PLK1) belongs to the family of serine/threonine kinases and plays an important role in centrosome maturation, bipolar spindle formation, and cytokinesis during mitosis. We found in this study that PLK1 was aberrantly highly expressed in a variety of
    Jingjing Li et al.
    Oncotarget, 6(11), 9327-9340 (2015-04-15)
    Mitosis is choreographed by a number of protein kinases including polo-like kinases and Aurora kinases. As these kinases are frequently dysregulated in cancers, small-molecule inhibitors have been developed for targeted anticancer therapies. Given that PLK1 and Aurora kinases possess both
    Matthildi Valianou et al.
    Cell cycle (Georgetown, Tex.), 14(3), 399-407 (2015-01-08)
    The mechanistic target of rapamycin complex 1 (mTORC1) increases translation, cell size and angiogenesis, and inhibits autophagy. mTORC1 is negatively regulated by hamartin and tuberin, the protein products of the tumor suppressors TSC1 and TSC2 that are mutated in Tuberous

    Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

    Contact Technical Service